RD Lewis Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
RD Lewis Holdings's PFE Position: Q1 2026 in Review
RD Lewis Holdings reduced its Pfizer (PFE) stake by 10% in Q1 2026, selling an estimated $57.1K and leaving 18,792 shares worth $512K. The position accounts for 0.44% of the portfolio, ranked #52.
RD Lewis Holdings first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $617K in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- RD Lewis Holdings held 18,792 shares of Pfizer worth $512K as of Q1 2026.
- RD Lewis Holdings sold 2,145 Pfizer shares in Q1 2026, an estimated $57.1K.
- Pfizer made up 0.44% of RD Lewis Holdings's portfolio in Q1 2026, its #52 holding.
- RD Lewis Holdings first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- RD Lewis Holdings's Pfizer position peaked at $617K in Q4 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on RD Lewis Holdings's 13F filing for Q1 2026, filed 14 Apr 2026.